table of content
1 Study Coverage
1.1 Biological Drugs Product Introduction
1.2 Global Biological Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Biological Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Biological Drugs Sales in Volume for the Year 2017-2028
1.3 United States Biological Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Biological Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Biological Drugs Sales in Volume for the Year 2017-2028
1.4 Biological Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Biological Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Biological Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Biological Drugs Market Dynamics
1.5.1 Biological Drugs Industry Trends
1.5.2 Biological Drugs Market Drivers
1.5.3 Biological Drugs Market Challenges
1.5.4 Biological Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Biological Drugs Market Segment by Type
2.1.1 Therapeutic Protein
2.1.2 Monoclonal Antibody
2.1.3 Vaccine
2.1.4 Others
2.2 Global Biological Drugs Market Size by Type
2.2.1 Global Biological Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Biological Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Biological Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Biological Drugs Market Size by Type
2.3.1 United States Biological Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Biological Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Biological Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Biological Drugs Market Segment by Application
3.1.1 Hospitals
3.1.2 Ambulatory Surgical Centers
3.1.3 Others
3.2 Global Biological Drugs Market Size by Application
3.2.1 Global Biological Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Biological Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Biological Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Biological Drugs Market Size by Application
3.3.1 United States Biological Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Biological Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Biological Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Biological Drugs Competitor Landscape by Company
4.1 Global Biological Drugs Market Size by Company
4.1.1 Top Global Biological Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Biological Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Biological Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Biological Drugs Price by Manufacturer (2017-2022)
4.2 Global Biological Drugs Concentration Ratio (CR)
4.2.1 Biological Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Biological Drugs in 2021
4.2.3 Global Biological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Biological Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Biological Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Biological Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Biological Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Biological Drugs Market Size by Company
4.5.1 Top Biological Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Biological Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Biological Drugs Sales by Players (2020, 2021 & 2022)
5 Global Biological Drugs Market Size by Region
5.1 Global Biological Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Biological Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Biological Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Biological Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Biological Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Biological Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Biological Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Biological Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Biological Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Biological Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Biological Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Biological Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Biological Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Biological Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Biological Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Biological Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Biological Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Bristol-Myers Squibb
7.1.1 Bristol-Myers Squibb Corporation Information
7.1.2 Bristol-Myers Squibb Description and Business Overview
7.1.3 Bristol-Myers Squibb Biological Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Bristol-Myers Squibb Biological Drugs Products Offered
7.1.5 Bristol-Myers Squibb Recent Development
7.2 Eli Lilly
7.2.1 Eli Lilly Corporation Information
7.2.2 Eli Lilly Description and Business Overview
7.2.3 Eli Lilly Biological Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Eli Lilly Biological Drugs Products Offered
7.2.5 Eli Lilly Recent Development
7.3 Takeda
7.3.1 Takeda Corporation Information
7.3.2 Takeda Description and Business Overview
7.3.3 Takeda Biological Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Takeda Biological Drugs Products Offered
7.3.5 Takeda Recent Development
7.4 Pfizer
7.4.1 Pfizer Corporation Information
7.4.2 Pfizer Description and Business Overview
7.4.3 Pfizer Biological Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Pfizer Biological Drugs Products Offered
7.4.5 Pfizer Recent Development
7.5 Amgen
7.5.1 Amgen Corporation Information
7.5.2 Amgen Description and Business Overview
7.5.3 Amgen Biological Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Amgen Biological Drugs Products Offered
7.5.5 Amgen Recent Development
7.6 F. Hoffmann-La Roche
7.6.1 F. Hoffmann-La Roche Corporation Information
7.6.2 F. Hoffmann-La Roche Description and Business Overview
7.6.3 F. Hoffmann-La Roche Biological Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 F. Hoffmann-La Roche Biological Drugs Products Offered
7.6.5 F. Hoffmann-La Roche Recent Development
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Corporation Information
7.7.2 Johnson & Johnson Description and Business Overview
7.7.3 Johnson & Johnson Biological Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Johnson & Johnson Biological Drugs Products Offered
7.7.5 Johnson & Johnson Recent Development
7.8 Merck
7.8.1 Merck Corporation Information
7.8.2 Merck Description and Business Overview
7.8.3 Merck Biological Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Merck Biological Drugs Products Offered
7.8.5 Merck Recent Development
7.9 Abbott Laboratories
7.9.1 Abbott Laboratories Corporation Information
7.9.2 Abbott Laboratories Description and Business Overview
7.9.3 Abbott Laboratories Biological Drugs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Abbott Laboratories Biological Drugs Products Offered
7.9.5 Abbott Laboratories Recent Development
7.10 Baxter
7.10.1 Baxter Corporation Information
7.10.2 Baxter Description and Business Overview
7.10.3 Baxter Biological Drugs Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Baxter Biological Drugs Products Offered
7.10.5 Baxter Recent Development
7.11 Novartis
7.11.1 Novartis Corporation Information
7.11.2 Novartis Description and Business Overview
7.11.3 Novartis Biological Drugs Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Novartis Biological Drugs Products Offered
7.11.5 Novartis Recent Development
7.12 Biogen
7.12.1 Biogen Corporation Information
7.12.2 Biogen Description and Business Overview
7.12.3 Biogen Biological Drugs Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Biogen Products Offered
7.12.5 Biogen Recent Development
7.13 GlaxoSmithKline
7.13.1 GlaxoSmithKline Corporation Information
7.13.2 GlaxoSmithKline Description and Business Overview
7.13.3 GlaxoSmithKline Biological Drugs Sales, Revenue and Gross Margin (2017-2022)
7.13.4 GlaxoSmithKline Products Offered
7.13.5 GlaxoSmithKline Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Biological Drugs Industry Chain Analysis
8.2 Biological Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Biological Drugs Distributors
8.3 Biological Drugs Production Mode & Process
8.4 Biological Drugs Sales and Marketing
8.4.1 Biological Drugs Sales Channels
8.4.2 Biological Drugs Distributors
8.5 Biological Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
